Catalyst Wire Dossier Catalyst Wire Dossier

Obeticholic acid (Ocaliva)

obeticholic acid · Intercept Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Obeticholic acid (Ocaliva), covering 2023-12-13 to 2023-12-13. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients [Phase 2]

See pricing